Javascript must be enabled to continue!
Dorsal Hippocampal Activation Suppresses Neuropathic Pain Behaviors: Chronic pain as extinction-resistant pain-related memory traces
View through CrossRef
AbstractAccumulating evidence suggests the hippocampus being involved in, and modified with, chronic neuropathic pain. However, it is still not clear whether hippocampal activity has direct control over neuropathic behaviors. Here we show that activation of the dorsal, but not ventral, hippocampus, by glutamate microinjection or by chemogenetically increasing excitability (PSAM/PSEM), completely or partially reversed neuropathic behaviors: tactile allodynia and thermal hyperalgesia in the models of spared nerve injury and lumbar spinal nerve ligation. Using a new methodology (chemo-fMRI), where we combine awake resting state brain imaging with viral vector mediated chemogenetic activation (PSAM/PSEM), we could demonstrate that increased excitability of dorsal hippocampus neurons altered resting state functional connectivity within circuitry specifically related to the extent of diminution of neuropathic behavior (tactile allodynia). The identified circuitry most reliably (survived a validation procedure) identified dorsal hippocampal connections to the somatosensory cortex and the thalamus. Moreover, anterograde tracing indicated non-overlapping projections from dorsal and ventral hippocampus. Thus, the present study exhibits a novel causal role for the dorsal hippocampus, and mediating circuitry, controlling neuropathic pain-related behaviors. Altogether, these results imply downregulation of dorsal hippocampus circuitry in chronic neuropathic pain; the activation of which reverses pain behaviors either through disruption of accumulated memories and/or by enhancing extinction circuitry.
Cold Spring Harbor Laboratory
Title: Dorsal Hippocampal Activation Suppresses Neuropathic Pain Behaviors: Chronic pain as extinction-resistant pain-related memory traces
Description:
AbstractAccumulating evidence suggests the hippocampus being involved in, and modified with, chronic neuropathic pain.
However, it is still not clear whether hippocampal activity has direct control over neuropathic behaviors.
Here we show that activation of the dorsal, but not ventral, hippocampus, by glutamate microinjection or by chemogenetically increasing excitability (PSAM/PSEM), completely or partially reversed neuropathic behaviors: tactile allodynia and thermal hyperalgesia in the models of spared nerve injury and lumbar spinal nerve ligation.
Using a new methodology (chemo-fMRI), where we combine awake resting state brain imaging with viral vector mediated chemogenetic activation (PSAM/PSEM), we could demonstrate that increased excitability of dorsal hippocampus neurons altered resting state functional connectivity within circuitry specifically related to the extent of diminution of neuropathic behavior (tactile allodynia).
The identified circuitry most reliably (survived a validation procedure) identified dorsal hippocampal connections to the somatosensory cortex and the thalamus.
Moreover, anterograde tracing indicated non-overlapping projections from dorsal and ventral hippocampus.
Thus, the present study exhibits a novel causal role for the dorsal hippocampus, and mediating circuitry, controlling neuropathic pain-related behaviors.
Altogether, these results imply downregulation of dorsal hippocampus circuitry in chronic neuropathic pain; the activation of which reverses pain behaviors either through disruption of accumulated memories and/or by enhancing extinction circuitry.
Related Results
Morphological study of dorsal Barton's fracture based on three-dimensional CT imaging
Morphological study of dorsal Barton's fracture based on three-dimensional CT imaging
Abstract
Background
Dorsal Barton's fracture is a distinct type of distal radius fracture. The treatment of dorsal Barton's fracture is contentious and may lead to severe ...
NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain
NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain
Neuropathic pain represents a serious complication arising from a spectrum of disorders that precipitate lesions within the central and peripheral nervous systems. This disabling p...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Human Extinction from Natural Hazard Events
Human Extinction from Natural Hazard Events
Like any other species, Homo sapiens can potentially go extinct. This risk is an existential risk: a threat to the entire future of the species (and possible descendants). While an...
Memory Function Related to Hippocampal Imaging Findings
Memory Function Related to Hippocampal Imaging Findings
Bilateral Hippocampal Atrophy: Consequences to Verbal Memory Following Temporal Lobectomy Martin RC, Sawrie SM, Knowlton RC, Bilir E, Gilliam FG, Faught E, Morawetz RB, Kuzniecky ...
The Role of Fat Grafting in Alleviating Neuropathic Pain: A Critical Review of the Literature
The Role of Fat Grafting in Alleviating Neuropathic Pain: A Critical Review of the Literature
Background:
Neuropathic pain is one of the more severe types of chronic pain and presents a great challenge as response to medical therapy remains often unpredictable. ...
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract
Chemotherapy-induced peripheral neuropathy is a dose-limiting debilitating symptom that can affect many patients treated with anticancer treatments. The res...
Blocking Cx43 alleviates neuropathic pain mediated by P2X4 receptor in CCI rats
Blocking Cx43 alleviates neuropathic pain mediated by P2X4 receptor in CCI rats
Abstract
Background: The current treatment strategy for pain is still the application of traditional analgesic drugs to relieve pain but with many side effects. Therefore, ...

